Brett P Monia Ionis Pharmaceuticals Inc (IONS) insider trading activity

Brett P Monia is Chief Executive Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 167,393 shares of IONS, which is worth approximately $6.01 Million. The most recent transaction as insider was on Nov 12, 2024, when has been sold 6,630 shares (Common Stock) at a price of $38.05 per share, resulting in proceeds of $252,271. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 167K

3.81% 3M change

41.73% 12M change

Total Value Held $6.01 Million

Brett P Monia Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 12 2024	SELL Open market or private sale	$252,271 $38.05 p/Share	6,630 Reduced 3.81%	167,393 Common Stock
Aug 30 2024	BUY Other acquisition or disposition	$5,409 $38.64 p/Share	140 Added 0.08%	174,023 Common Stock
Feb 29 2024	BUY Other acquisition or disposition	$18,517 $34.42 p/Share	538 Added 0.31%	174,289 Common Stock
Feb 16 2024	SELL Open market or private sale	$17,217 $44.49 p/Share	387 Reduced 0.22%	173,751 Common Stock
Feb 02 2024	SELL Open market or private sale	$1,160,244 $49.37 p/Share	23,501 Reduced 11.89%	174,138 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	45,788 Added 18.81%	197,639 Common Stock
Jan 25 2024	SELL Open market or private sale	$118,248 $51.75 p/Share	2,285 Reduced 1.48%	151,851 Common Stock
Jan 17 2024	SELL Open market or private sale	$1,616,414 $50.42 p/Share	32,059 Reduced 17.22%	154,136 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	68,084 Added 26.78%	186,195 Common Stock
Dec 21 2023	SELL Open market or private sale	$862,575 $49.29 p/Share	17,500 Reduced 12.9%	118,111 Common Stock
Dec 21 2023	BUY Exercise of conversion of derivative security	$828,450 $47.34 p/Share	17,500 Added 11.43%	135,611 Common Stock
Dec 20 2023	SELL Open market or private sale	$322,660 $49.64 p/Share	6,500 Reduced 5.22%	118,111 Common Stock
Dec 20 2023	BUY Exercise of conversion of derivative security	$307,710 $47.34 p/Share	6,500 Added 4.96%	124,611 Common Stock
Dec 14 2023	SELL Open market or private sale	$1,192,800 $49.7 p/Share	24,000 Reduced 16.89%	118,111 Common Stock
Dec 14 2023	BUY Exercise of conversion of derivative security	$1,136,160 $47.34 p/Share	24,000 Added 15.87%	127,251 Common Stock
Oct 12 2023	SELL Open market or private sale	$173,420 $46.0 p/Share	3,770 Reduced 3.09%	118,111 Common Stock
Aug 31 2023	BUY Other acquisition or disposition	$4,797 $30.56 p/Share	157 Added 0.13%	121,881 Common Stock
Jul 07 2023	SELL Open market or private sale	$787,962 $42.25 p/Share	18,650 Reduced 13.29%	121,724 Common Stock
May 22 2023	SELL Open market or private sale	$197,930 $40.14 p/Share	4,931 Reduced 3.39%	140,374 Common Stock
Feb 06 2023	SELL Open market or private sale	$1,003,049 $40.69 p/Share	24,651 Reduced 14.5%	145,305 Common Stock
Feb 03 2023	BUY Grant, award, or other acquisition	-	49,093 Added 22.41%	169,956 Common Stock
Jan 18 2023	SELL Open market or private sale	$989,856 $39.49 p/Share	25,066 Reduced 17.18%	120,863 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	57,267 Added 28.18%	145,929 Common Stock
Apr 01 2022	SELL Open market or private sale	$13,309 $37.49 p/Share	355 Reduced 0.4%	88,662 Common Stock
Feb 28 2022	BUY Other acquisition or disposition	$17,618 $28.37 p/Share	621 Added 0.69%	89,017 Common Stock

Also insider at

CGTX

COGNITION THERAPEUTICS INC Healthcare

Director

BPM

Brett P Monia

Chief Executive Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account